• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

SOBI:SS

78.5500 SEK 1.1000 1.38%

As of 11:29:59 ET on 12/23/2014.

Snapshot for Swedish Orphan Biovitrum AB (SOBI)

Open: 80.0000 Day's Range: 76.9000 - 80.1500 Volume: 584,524
Previous Close: 79.6500 52wk Range: 64.0000 - 94.7500 1-Yr Rtn: +18.12%

Stock Chart for SOBI

No chart data available.
  • SOBI:SS 78.5500
  • 1D
  • 1M
  • 1Y
79.6500
Interactive SOBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SOBI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 187.9187
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.9700
Est. EPS (SEK) (12/2014) 0.4180
Est. PEG Ratio -
Market Cap (M SEK) 21,239.12
Shares Outstanding (M) 270.39
30 Day Average Volume 640,520
Price/Book (mrq) 4.6198
Price/Sale (ttm) 8.3378
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SOBI

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for SOBI

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for SOBI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil